Sign in →

Epic Test Code LAB101011 Phosphatidylethanol Confirmation, Blood

Additional Codes

MML:PETH


Specimen Required


Container/Tube: Lavender top (EDTA)

Specimen Volume: 1 mL

Collection Instructions:

1. Do not use alcohol to clean arm. Use alternatives such as Betadine or ChloraPrep to cleanse arm before collecting any specimen.

2. Do not centrifuge.

3. Send whole blood specimen in original tube. Do not aliquot.


Useful For

Verifying abstinence or use of ethanol, especially in liver transplant candidates/patients

Method Name

Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)

Reporting Name

Phosphatidylethanol Confirmation, B

Specimen Type

Whole Blood EDTA

Specimen Minimum Volume

0.5 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Whole Blood EDTA Frozen (preferred) 28 days
  Refrigerated  14 days

Reject Due To

Gross lipemia OK
Gross icterus OK

Clinical Information

Phosphatidylethanol (PEth) is a direct biomarker for alcohol (ethanol) intake. In presence of ethanol, phosphatidylcholine is converted to PEth on the red blood cell membrane by the phospholipase D enzyme. PEth homologues (16:0/18:1 [POPEth: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol] and 16:0/18:2 [PLPEth: 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphoethanol]) levels correlate with the amount of alcohol consumed within the previous 2 weeks and may be detected in the blood up to 2 to 4 weeks after excessive alcohol consumption. POPEth and PLPEth comprise approximately 60% of all observed PEth homologues in the blood.(1)

Reference Values

Negative (<10 ng/mL)

 

PEth 16:0/18:1 (POPEth): Lower limit of quantification =10 ng/mL

PEth 16:0/18:2 (PLPEth): Lower limit of quantification =10 ng/mL

Interpretation

POPEth (1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol):

A result of 20 ng/mL to 200 ng/mL is considered evidence of moderate ethanol consumption, while results over 200 ng/mL indicate heavy ethanol consumption. However, the Center for Substance Abuse Treatment advises caution in interpretation and use of biomarkers alone to assess alcohol use. Results should be interpreted in the context of all available clinical and behavioral information.(2)

 

PLPEth (1-Palmitoyl-2-linoleoyl-sn-glycero-3-phosphoethanol):

There are no current clinical reference limits for this phosphatidylethanol (PEth) homologue.

 

PEth 16:0/18:1 (POPEth)

Less than 10 ng/mL: Not detected

10-19 ng/mL: Abstinence or light alcohol consumption (<2 drinks per day for several days a week)

20-200 ng/mL: Moderate alcohol consumption (up to 4 drinks per day for several days a week)

Greater than 200 ng/mL: Heavy alcohol consumption or chronic alcohol use (at least 4 drinks per day several days a week)

 

PEth 16:0/18:2 (PLPEth): Reference ranges are not well established.

Cautions

No significant cautionary statements

Day(s) Performed

Monday through Sunday

Report Available

2 to 5 days

Specimen Retention Time

14 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

80321

G0480 (if appropriate)

NY State Approved

Yes

Forms

If not ordering electronically, complete, print, and send 1 of the following with the specimen:

-Therapeutics Test Request (T831)

-General Test Request (T239)

-Renal Diagnostics Test Request (T830)